Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Brain Neoplasms/secondary"'
Health-related quality of life after Gamma Knife radiosurgery in patients with 1–10 brain metastases
Autor:
Wietske C. M. Schimmel, Wilco H. M. Emons, Patrick E J Hanssens, Karin Gehring, Eline Verhaak, Margriet M. Sitskoorn
Publikováno v:
Journal of Cancer Research and Clinical Oncology, 147(4), 1157-1167. Springer Verlag
Purpose Increasingly more patients with multiple (> 4) brain metastases (BM) are being treated with stereotactic radiosurgery (SRS). Preserving patients’ health-related quality of life (HRQoL) is an important treatment goal. The aim of this study w
Autor:
Monteiro, Cátia, Miarka, Lauritz, Perea-García, María, Priego, Neibla, García-Gómez, Pedro, Álvaro-Espinosa, Laura, de Pablos-Aragoneses, Ana, Yebra, Natalia, Retana, Diana, Baena, Patricia, Fustero-Torre, Coral, Graña-Castro, Osvaldo, Troulé, Kevin, Caleiras, Eduardo, Tezanos, Patricia, Muela, Pablo, Cintado, Elisa, Trejo, José Luis, Sepúlveda, Juan Manuel, González-León, Pedro, Jiménez-Roldán, Luis, Moreno, Luis Miguel, Esteban, Olga, Pérez-Núñez, Ángel, Hernández-Lain, Aurelio, Mazarico Gallego, José, Ferrer, Irene, Suárez, Rocío, Garrido-Martín, Eva M., Paz-Ares, Luis, Dalmasso, Celine, Cohen-Jonathan Moyal, Elizabeth, Siegfried, Aurore, Hegarty, Aisling, Keelan, Stephen, Varešlija, Damir, Young, Leonie S., Mohme, Malte, Goy, Yvonne, Wikman, Harriet, Fernández-Alén, Jose, Blasco, Guillermo, Alcázar, Lucía, Cabañuz, Clara, Grivennikov, Sergei I., Ianus, Andrada, Shemesh, Noam, Faria, Claudia, Lee, Rebecca, Lorigan, Paul, Le Rhun, Emilie, Weller, Michael, Soffietti, Riccardo, Bertero, Luca, Ricardi, Umberto, Bosch-Barrera, Joaquim, Sais, Elia, Teixidor, Eduard, Hernández-Martínez, Alejandro, Calvo, Alfonso, Aristu, Javier, Martin, Santiago M., Gonzalez, Alvaro, Adler, Omer, Erez, Neta, Sobrino, Cecilia, Ajenjo, Nuria, Artiga, Maria-Jesus, Ortega-Paino, Eva, Valiente, Manuel
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
RENACER 2022, ' Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism ', Nature Medicine, vol. 28, no. 4, pp. 752-765 . https://doi.org/10.1038/s41591-022-01749-8
instname
RENACER 2022, ' Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism ', Nature Medicine, vol. 28, no. 4, pp. 752-765 . https://doi.org/10.1038/s41591-022-01749-8
Whole-brain radiotherapy (WBRT) is the treatment backbone for many patients with brain metastasis; however, its efficacy in preventing disease progression and the associated toxicity have questioned the clinical impact of this approach and emphasized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cd2fa1d99f11c0ccef1ace8e8a7bec4
http://hdl.handle.net/10261/281906
http://hdl.handle.net/10261/281906
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 23(6)
Purpose: E-cadherin is a calcium-dependent glycoprotein whose main role is cell-cell adhesion. Its transcriptional repressor TWIST1 is a basic helix-loop-helix (bHLH) protein that participates in gastrulation and formation of mesodermal tissues durin
Autor:
Dennis J. Slamon, Thomas Bachelot, Erik Jakobsen, Rashmi Krishna Murthy, Alicia Okines, David Cameron, Lisa A. Carey, Giuseppe Curigliano, Ian E. Krop, Karen A. Gelmon, Volkmar Müller, Nan Lin, Virginia F. Borges, Eric P. Winer, Gabriel N. Hortobagyi, Philippe L. Bedard, Richard Greil, Sara A. Hurvitz, François Duhoux, Luke Walker, Sofia Braga, Elisavet Paplomata, M Corinna Palanca-Wessels, Sherene Loi, Vandana G. Abramson, Mafalda Oliveira, Carey K. Anders, Wentao Feng, Mark D. Pegram, Shlomit S. Shachar, Sibylle Loibl, Erika Hamilton
Publikováno v:
K Murthy, R, Loi, S, Okines, A, Paplomata, E, Hamilton, E, A. Hurvitz, S, U. Lin, N, Borges, V, Abramson, V, Anders, C, L. Bedard, P, Oliveira, M, Jakobsen, E, Bachelot, T, S. Shachar, S, Müller, V, Braga, S, P. Duhoux, F, Greil, R, Cameron, D, A. Carey, L, Curigliano, G, Gelmon, K, Hortobagyi, G, Krop, I, Loibl, S, Pegram, M, Slamon, D, Palanca-Wessels, M C, Walker, L, Feng, W & P. Winer, E 2020, ' Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer ', New England Journal of Medicine, vol. 382, no. 7, pp. 597-609 . https://doi.org/10.1056/NEJMoa1914609
Murthy, R K, Loi, S, Okines, A, Paplomata, E, Hamilton, E, Hurvitz, S A, Lin, N U, Borges, V, Abramson, V, Anders, C, Bedard, P L, Oliveira, M, Jakobsen, E, Bachelot, T, Shachar, S S, Muller, V, Braga, S, Duhoux, F P, Greil, R, Cameron, D, Carey, L A, Curigliano, G, Gelmon, K, Hortobagyi, G, Krop, I, Loibl, S, Pegram, M, Slamon, D, Palanca-Wessels, M C, Walker, L, Feng, W & Winer, E P 2020, ' Tucatinib, trastuzumab, and capecitabine for HER2-positive metastatic breast cancer ', New England Journal of Medicine, vol. 382, no. 7, pp. 597-609 . https://doi.org/10.1056/NEJMoa1914609
The New England journal of medicine, Vol. 382, no. 7, p. 597-609 (2020)
Murthy, R K, Loi, S, Okines, A, Paplomata, E, Hamilton, E, Hurvitz, S A, Lin, N U, Borges, V, Abramson, V, Anders, C, Bedard, P L, Oliveira, M, Jakobsen, E, Bachelot, T, Shachar, S S, Muller, V, Braga, S, Duhoux, F P, Greil, R, Cameron, D, Carey, L A, Curigliano, G, Gelmon, K, Hortobagyi, G, Krop, I, Loibl, S, Pegram, M, Slamon, D, Palanca-Wessels, M C, Walker, L, Feng, W & Winer, E P 2020, ' Tucatinib, trastuzumab, and capecitabine for HER2-positive metastatic breast cancer ', New England Journal of Medicine, vol. 382, no. 7, pp. 597-609 . https://doi.org/10.1056/NEJMoa1914609
The New England journal of medicine, Vol. 382, no. 7, p. 597-609 (2020)
BACKGROUND: Patients with human epidermal growth factor receptor 2 (HER2)–positive metastatic breast cancer who have disease progression after therapy with multiple HER2-targeted agents have limited treatment options. Tucatinib is an investigationa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5309a1bc026281d5d475def4ba6ca36
https://www.pure.ed.ac.uk/ws/files/125147047/NEJMoa1914609.pdf
https://www.pure.ed.ac.uk/ws/files/125147047/NEJMoa1914609.pdf
Autor:
Alice T. Shaw, Shirish M. Gadgeel, Solange Peters, S-H.I. Ou, Silvia Novello, Ali Zeaiter, Maurice Pérol, Anna Wrona, D.R. Camidge, Dong Wan Kim, Bogdana Balas, Eveline Nüesch, Ting Liu, Tony Mok, Rafael Rosell
Publikováno v:
Annals of oncology, vol. 29, no. 11, pp. 2214-2222
The phase III ALEX study in patients with treatment-naive advanced anaplastic lymphoma kinase mutation-positive (ALK+) non-small-cell lung cancer (NSCLC) met its primary end point of improved progression-free survival (PFS) with alectinib versus criz
Publikováno v:
Archives of Clinical Psychiatry (São Paulo), Volume: 44, Issue: 2, Pages: 53-54, Published: APR 2017
Archives of Clinical Psychiatry, Vol 44, Iss 2, Pp 53-54
Archives of Clinical Psychiatry, Vol 44, Iss 2, Pp 53-54
Background Metastatic tumours sometimes present with neuropsychiatric symptoms, however psychiatric symptoms as rarely the first clinical manifestation. Cutaneous melanoma is the third most common cause of brain metastasis, with known risk factors in
Autor:
Lee D. Cranmer, Sigrun Hallmeyer, Rene Gonzalez, Anna C. Pavlick, John D. Hainsworth, F. Stephen Hodi, Lynn M. Schuchter, Bann Mo Day, C. Lance Cowey, David F. McDermott, David H. Lawson, R. Linke, Fred J. Kudrik, Brendan D. Curti, Paul B. Chapman, Kim Margolin, Keith T. Flaherty, Omid Hamid, Gerald P. Linette, Antoni Ribas, Lawrence E. Flaherty
Publikováno v:
Cancer journal (Sudbury, Mass.), vol 20, iss 1
Purpose This open-label, multicenter study was designed to allow access to vemurafenib for patients with metastatic melanoma, bridging the time between end of enrollment in the phase III registration trial (December 2010) and commercial availability
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b3953e48760c3f30385fbbce2f234de
https://escholarship.org/uc/item/6jv605j1
https://escholarship.org/uc/item/6jv605j1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Zigouris, A., Pahatouridis, D., Mihos, E., Alexiou, G. A., Nesseris, J., Zikou, A. K., Argyropoulou, M. I., Goussia, A., Voulgaris, S.
Metastatic brain tumors are the most common intracranial neoplasm in adults. Bladder cancer gives metastasis to the brain in less than 1%. Herewith, we report on a case of a 71-year-old man who was admitted to the emergency department after an episod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10561::57a5bf812d4dd78f110ecd739b7ff083
http://olympias.lib.uoi.gr/jspui/handle/123456789/18208
http://olympias.lib.uoi.gr/jspui/handle/123456789/18208
Autor:
Huda Abusaris, Robert C. Miller, Yavuz Anacak, Alessia Pica, Salvador Villà, Gokhan Ozyigit, Brigitta G. Baumert, Renata Zaucha, Guy Haller, Sidney P. Kadish, Damien C. Weber
Publikováno v:
International Journal of Radiation Oncology, Biology, Physics, Vol. 74, No 4 (2009) pp. 1114-20
PURPOSE: The aim of this study was to assess the outcome of patients with primary spinal myxopapillary ependymoma (MPE). MATERIALS AND METHODS: Data from a series of 85 (35 females, 50 males) patients with spinal MPE were collected in this retrospect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ccee7478fd19e59c116f3318df69569
https://archive-ouverte.unige.ch/unige:5463
https://archive-ouverte.unige.ch/unige:5463